Wedge Capital Management L L P Pacira Bio Sciences, Inc. Transaction History
Wedge Capital Management L L P
- $6.04 Billion
- Q1 2024
A detailed history of Wedge Capital Management L L P transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Wedge Capital Management L L P holds 56,383 shares of PCRX stock, worth $1.19 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
56,383
Previous 31,414
79.48%
Holding current value
$1.19 Million
Previous $1.06 Million
55.52%
% of portfolio
0.03%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding PCRX
# of Institutions
287Shares Held
48.7MCall Options Held
156KPut Options Held
623K-
Black Rock Inc. New York, NY7.91MShares$166 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$108 Million0.0% of portfolio
-
Frontier Capital Management CO LLC1.91MShares$40.3 Million0.55% of portfolio
-
State Street Corp Boston, MA1.9MShares$40.1 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.88MShares$39.6 Million0.09% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $965M
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...